IRCT20200407046981N19招募中未知
Comparative bioequivalence study of the Omeprazole 20 mg capsules manufactured by Yas Kavir Meybod Pharmaceutical Company versus Prilosec® (AstraZeneca Company)
Yas Kavir Meybod Pharmaceutical Company0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- Male
入选标准
- •The weight limit of each volunteer should be between 60 and 100 kg.
- •All volunteers must be non-smokers.
- •They must be healthy in terms of liver, kidney, respiratory system, mental and other general health characteristics that will be assessed.
- •Candidates who have consented to the consent form.
排除标准
- •Known hypersensitivity or idiosyncratic reaction to omeprazole or any ingredients.
- •Subjects with BP = 90/60 mm/Hg or BP = 140/90 mm/Hg.
- •Regular smoker who smokes more than ten cigarettes daily.
- •Taking any medicine during two week before dosing.
研究者
相似试验
尚未招募
不适用
Study of absorption and elimination rate of omeprazole 10-mg Sachet in comparison with omeprazole brand Sachet (Nexium®).IRCT20200407046981N20Kimia Kala Razi Pharmaceutical Company24
已完成
不适用
Comparative bioequivalence study of the Omeprazole 10-mg Sachet manufactured by Nafas Zist Pharmed Pharmaceutical CompanyIRCT20130313012810N9afas Zist Pharmed Pharmaceutical Company24
招募中
Unknown
Investigating bioequivalence of Omeprazole capsuleIn the present study, the products will be administered to healthy volunteers..IRCT20220211053992N16Tabriz University of Medical Sciences24
尚未招募
不适用
The comparison of the efficacy of two therapeutic regimens in the treatment of gastroesophageal reflux disease in term neonates.IRCT20160827029535N10Tehran University of Medical Sciences120
已完成
不适用
Bioequivalance study of Omeprazole 20mgIRCT20200513047423N2Sina Pishgam Darou Novin24